Assessment of a New Novel Fluid Monitoring Device in Heart Failure Patients
Not Applicable
Completed
- Conditions
- Congestive heart failure (CHF)Cardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12619000960156
- Lead Sponsor
- Safehouse Innovation Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
•Male and female Age 18 years+
•Heart failure Condition
•Hospitalised with significant fluid overload for fluid offload.
•Ability to give written informed consent and agree to adhere to all protocol requirements.
Exclusion Criteria
•Patient has been prescribed to wear TED stockings throughout the duration of their hospital stay.
•Leg prosthesis or other disorders making measurement of leg oedema difficult or inadvisable.
•Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective of the study is to record changes in bio-impedance over a three day period in hospitalised heart failure patients.[Participants will be directly recruited for the study following admission to the heart failure clinic or from the cardiac ward. Patients will be recruited when showing signs of significant fluid overload associated with a heart failure condition.]
- Secondary Outcome Measures
Name Time Method /A[N/A]